Aquestive Therapeutics, Inc.

Ownership Transactions Reported by 22 Insiders

Symbol
AQST on Nasdaq
Industry
Pharmaceutical Preparations
Location
30 Technology Drive, Warren, NJ

Insiders trading volume in the past year

Aquestive Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Alexander Mark Schobel Chief Innovation/Tech Officer $5.91M -$430K -6.78% Mar 15, 2024
Daniel Barber President and CEO $4.13M Mar 9, 2024
Stephen Wargacki Chief Science Officer $1.61M May 10, 2024
Lori Braender SVP, General Counsel $1.53M Mar 9, 2024
A. Ernest Toth Jr SVP, Chief Financial Officer $1.21M Mar 9, 2024
Cassie Jung SVP, Operations $1.17M Mar 9, 2024
Peter E. Boyd SVP, Information Technology, Human Resources and Communications $1.16M Mar 9, 2024
Carl N. Kraus Chief Medical Officer $863K Aug 9, 2024
John Cochran Director $597K Jun 20, 2024
Keith J. Kendall CEO and President, Director $516K Mar 10, 2022
Gregory B. Brown Director $451K Jun 20, 2024
Sherry Korczynski SVP Sales and Marketing $150K Jun 7, 2024
Ken W. Marshall SVP, Chief Commercial Officer $123K Aug 9, 2023
Santo J. Costa Director $104K Jun 20, 2024
James S. Scibetta Director $25.6K Jun 15, 2021
Abigail L. Jenkins Director $0 May 10, 2024
Marco Taglietti Director Jun 20, 2024
Timothy E. Morris Director Jun 20, 2024
Kenneth Truitt Chief Medical Officer Sep 6, 2022
Theresa Wood SVP-HR and Org. Development Mar 10, 2022
Nancy Lurker Director Jun 15, 2021
Julie Krop Director Jun 20, 2024

Recent Insider Transactions by Companies or Individuals for Aquestive Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.